The newly developed immunoblot assay, RlBA SIA (recombinant and synthetic polypeptide immunoblot assay), Chiron, Calif., was compared with the commercially available second generation recombinant immunoblot assay (RIBA-2) for the detection of antibody to hepatitis C virus (anti-HCV). The two immunob
Detection of hepatitis C virus by polymerase chain reaction and recombinant immunoblot assay 3.0 in porphyria cutanea tarda
β Scribed by Pietro Andreone; Carmela Cursaro; Annagiulia Gramenzi; Maria Silvia Guidetti; Frederico Bardazzi; Antonella Tosti; Rita Miniero; Silvia Fargion
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 252 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
In situ demonstration of Epstein-Barr virus small RNAs (EBERI) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site.
π SIMILAR VOLUMES
## Abstract The mean prevalence of antiβhepatitis C virus (HCV) in Italy is 0.87%. It reaches 2% in Campania, Southern Italy. Approximately 50% of community acquired nonβA, nonβB (NANB) hepatitis cannot be associated with known parenteral exposure. A recent Italian study has shown that the only dem
## Abstract Fiftyβseven sera with indeterminate results by the second generation RIBA (RIBA 2) for confirmation of hepatitis C virus (HCV) enzyme linked immunoassay (ELISA) reactivity were tested by the new third generation RIBA (RIBA 3). Thirty three (57.9%) displayed reactivity for at least one o
Three PCR methods based on the GB virus-C/ hepatitis G virus (GBV-C/HGV) 5ΠUTR and NS3 genomic region were used for the detection of GBV-C/HGV RNA in serum of 62 patients with chronic hepatitis C virus (HCV) infection. Ten of 62 (16%) patients were found to have GBV-C/ HGV RNA, which was confirmed b
GB Virus C/Hepatitis G Virus (GBV-C/HGV) was identified recently and only two assays, consisting of a single recombinant protein, have been described for determination of the seroprevalence of this virus. An immunoblot assay was devised, which contains four recombinant GBV-C/HGV proteins. In this st